Regeneron Gets OK for Huge Expansion in Greenburgh, New York Post author:Sam Post published:November 15, 2017 Post category:BioPharma When complete, the expansion is expected to double the size of Regeneron’s footprint in Greenburgh. Source: BioSpace You Might Also Like Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017 Dermira Presents New Data In Primary Axillary Hyperhidrosis And Acne At American Academy of Dermatology 2017 Annual Meeting March 2, 2017 Almirall Discontinues R&D for Two Drugs in the U.S. September 28, 2017
Phase I Clinical Data Of ABX464, ABIVAX's First-In-Class Anti-HIV Drug, Published In Two Articles In Peer-Reviewed Journals February 2, 2017
Dermira Presents New Data In Primary Axillary Hyperhidrosis And Acne At American Academy of Dermatology 2017 Annual Meeting March 2, 2017